CEO SUMMARY: AmeriPath’s new status as a public company gives it even greater visibility than before. As the first public pathology-based physician practice management firm, AmeriPath has the potential to introduce many innovations into the business organization of pathology services. With the IPO behind it, AmeriPath now faces hard work. WEDNESDAY, OCTOBER 22 was the […]
AmeriPath Successfully Completes Public Offering
Stock of first pathology-based PPM now trades on NASDAQ Market as “PATH"?
- By Robert Michel
- > From the Volume IV No. 15 - October 27, 1997 Issue
